Status:

UNKNOWN

Clinical Feature and Microbiology Characteristics of Empyema in Children

Lead Sponsor:

Beijing Children's Hospital

Collaborating Sponsors:

Capital Institute of Pediatrics, China

Tianjin Children's Hospital

Conditions:

Empyema

Eligibility:

All Genders

1-18 years

Brief Summary

The study is designed to clarify the clinical characteristics and reversion of children with empyema, observe the effect of streptococcus vaccine application on serotype of streptococcus, and to explo...

Detailed Description

Empyema is a major complication of bacterial community-acquired pneumonia in children. And studies have shown that although the incidence of community-acquired pneumonia in children has decreased with...

Eligibility Criteria

Inclusion

  • Age between 1 day to 18 years
  • Admitted with diagnosis of pneumonia combined with pleural effusion
  • The appearance of thoracic fluid or the results of fluid examination conforms to empyema with at least 1 of the following criteria:
  • Thoracentesis is pus.
  • Thoracic fluid smear observation show bacterial-positive.
  • Thoracic fluid culture test show bacterial-positive.
  • Cell counting of thoracic fluid is more than 10x109/L.

Exclusion

  • Subjects will be excluded if the thoracic fluids are caused by non-infectious factors, such as cardiovascular, connective tissue disease, tumor or trauma, etc.

Key Trial Info

Start Date :

January 6 2021

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

November 30 2022

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT04695275

Start Date

January 6 2021

End Date

November 30 2022

Last Update

January 5 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Beijing Children's Hospital,

Beijing, Beijing Municipality, China, 100045